Retraction

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia

Paper Information

Record ID:
26496
Publication Date:
November 14, 2014
Retraction Date:
March 03, 2021 (4.7 years years ago)
Subject:
Broad Categories:
Medicine
Specific Fields:
Medicine - Neurology
Article Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Citations (13)

13
Total Citations
1
Post-Retraction
(7.7%)
12
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
0 After 2+ years
379 Days since retraction (latest)
Sıçanlarda 6-hidroksidopamin modeli ile oluşturulan Parkinson hastalığında valproik asit tedavisinin dopaminerjik nöronal kayıp üzerindeki anti-apoptotik etkileri
Alev Cumbul, Signem EYUBOGLU, Elif Çiğdem Keleş et al. (5 authors)
Anadolu Kliniği Tıp Bilimleri Dergisi Open Access
Published: Mar 2022
379 days after retraction
Accelerated habitual learning resulting from L-dopa exposure in rats is prevented by N-acetylcysteine
Anne S. Gibson, Kristen A. Keefe, Teri M. Furlong
Pharmacology Biochemistry and Behavior Open Access
Published: Sep 2020
8 citations
182 days before retraction
Paper citing Parkinson’s Disease: Carbidopa, Nausea, and Dyskin...
Unknown Authors
Unknown Journal
Published: Sep 2020
183 days before retraction
The art of suicidal molecular seduction for targeting drug resistance
Mohammad Hassan Moshafi, Saeid Ghasemshirazi, Ardavan Abiri
Medical Hypotheses
Published: Mar 2020
1 citation
352 days before retraction
Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues
Yukihiro Yoshida, Hidetsugu Fujigaki, Koichi Kato et al. (11 authors)
Scientific Reports Open Access
Published: Jul 2019
24 citations
597 days before retraction
Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects
Frank Schneider, Lavi Erisson, Hooman Beygi et al. (15 authors)
British Journal of Clinical Pharmacology Open Access
Published: Jun 2018
35 citations
977 days before retraction
Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters
Gayan Jayawickrama, Alireza Nematollahi, Guanchen Sun et al. (4 authors)
PLoS ONE Open Access
Published: Apr 2018
13 citations
1044 days before retraction
Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives
Gayan Jayawickrama, Alireza Nematollahi, Guanchen Sun et al. (5 authors)
Scientific Reports Open Access
Published: Dec 2017
49 citations
1181 days before retraction
Management of Parkinson's disease in Ayurveda: Medicinal plants and adjuvant measures
Namyata Pathak- Gandhi, Ashok Vaidya
Journal of Ethnopharmacology
Published: Aug 2016
55 citations
1656 days before retraction
Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry
Philippe De Deurwaerdère, Giuseppe Di Giovanni, Mark J. Millan
Progress in Neurobiology
Published: Jul 2016
114 citations
1703 days before retraction
Study of the Activity and Possible Mechanism of Action of a Reversible Inhibitor of Recombinant Human KAT-2: A Promising Lead in Neurodegenerative and Cognitive Disorders
Alireza Nematollahi, Guanchen Sun, Gayan Jayawickrama et al. (5 authors)
Molecules Open Access
Published: Jun 2016
19 citations
1708 days before retraction
Parkinson’s disease managing reversible neurodegeneration
Marty Hinz, Alvin Stein, Ted Cole et al. (5 authors)
Neuropsychiatric Disease and Treatment Open Access
Published: Apr 2016
3 citations
1797 days before retraction
Related Records

This article has multiple records in the database due to different notices:

Record #23231
Apr 23, 2020
Expression of concern
Quick Stats
Total Citations: 13
Years Since Retraction: 4.7 years
Open Access: Yes
Last Checked: Jul 24, 2025